Literature DB >> 15781317

Role of matrix metalloproteinases in melanoma cell invasion.

Uta B Hofmann1, Roland Houben, Eva-B Bröcker, Jürgen C Becker.   

Abstract

Cutaneous melanomas are notorious for their tendency to metastasize. Essential steps in this process are the degradation of basement membranes and remodeling of the extracellular matrix (ECM) by proteolytic enzymes such as matrix metalloproteinases (MMPs), which are regulated by their tissue inhibitors (TIMPs). An MMP expression is not restricted to tumor cells but is also found in stromal cells, indicating that stroma-derived proteases may contribute to melanoma progression. The MMPs have been shown to interact with a broad range of non-matrix proteins including adhesion molecules, growth factors and mediators of angiogenesis and apoptosis. In this review, we evaluate new insights into the interplay of MMPs and their molecular partners in melanoma progression.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15781317     DOI: 10.1016/j.biochi.2005.01.013

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  55 in total

1.  Monitoring mmp-9 gene expression in stromal cells using a novel transgenic mouse model.

Authors:  Katherine Biron-Pain; Yves St-Pierre
Journal:  Cell Mol Life Sci       Date:  2011-08-11       Impact factor: 9.261

2.  Mechanochemical feedback underlies coexistence of qualitatively distinct cell polarity patterns within diverse cell populations.

Authors:  JinSeok Park; William R Holmes; Sung Hoon Lee; Hong-Nam Kim; Deok-Ho Kim; Moon Kyu Kwak; Chiaochun Joanne Wang; Leah Edelstein-Keshet; Andre Levchenko
Journal:  Proc Natl Acad Sci U S A       Date:  2017-06-27       Impact factor: 11.205

3.  Local inhibition of angiogenesis by halofuginone coated silicone materials.

Authors:  Martin C Jordan; Philip H Zeplin
Journal:  J Mater Sci Mater Med       Date:  2012-03-16       Impact factor: 3.896

4.  Cyclophilin A promotes human hepatocellular carcinoma cell metastasis via regulation of MMP3 and MMP9.

Authors:  Mingjun Zhang; Chun Dai; Hengrui Zhu; Shuai Chen; Yanhua Wu; Qiang Li; Xianzhuo Zeng; Wenzhang Wang; Jie Zuo; Mei Zhou; Zongjun Xia; Guoqing Ji; Hexige Saiyin; Lunxiu Qin; Long Yu
Journal:  Mol Cell Biochem       Date:  2011-06-11       Impact factor: 3.396

5.  Specific targeting of Wnt/β-catenin signaling in human melanoma cells by a dietary triterpene lupeol.

Authors:  Rohinton S Tarapore; Imtiaz A Siddiqui; Mohammad Saleem; Vaqar M Adhami; Vladimir S Spiegelman; Hasan Mukhtar
Journal:  Carcinogenesis       Date:  2010-08-23       Impact factor: 4.944

6.  Fibroblasts protect melanoma cells from the cytotoxic effects of doxorubicin.

Authors:  Manoela Tiago; Edson Mendes de Oliveira; Carla Abdo Brohem; Paula Comune Pennacchi; Rafael Duarte Paes; Raquel Brandão Haga; Ana Campa; Silvia Berlanga de Moraes Barros; Keiran S Smalley; Silvya Stuchi Maria-Engler
Journal:  Tissue Eng Part A       Date:  2014-03-25       Impact factor: 3.845

7.  Assaying Wnt5A-mediated invasion in melanoma cells.

Authors:  Michael P O'Connell; Amanda D French; Poloko D Leotlela; Ashani T Weeraratna
Journal:  Methods Mol Biol       Date:  2008

8.  Preclinical studies of celastrol and acetyl isogambogic acid in melanoma.

Authors:  Sabiha Abbas; Anindita Bhoumik; Russell Dahl; Stefan Vasile; Stan Krajewski; Nicholas D P Cosford; Ze'ev A Ronai
Journal:  Clin Cancer Res       Date:  2007-11-15       Impact factor: 12.531

9.  A matrix metalloproteinase-1/protease activated receptor-1 signaling axis promotes melanoma invasion and metastasis.

Authors:  J S Blackburn; I Liu; C I Coon; C E Brinckerhoff
Journal:  Oncogene       Date:  2009-09-07       Impact factor: 9.867

10.  CD8+ T cell concentration determines their efficiency in killing cognate antigen-expressing syngeneic mammalian cells in vitro and in mouse tissues.

Authors:  Sadna Budhu; John D Loike; Ashley Pandolfi; Soo Han; Geoffrey Catalano; Andrei Constantinescu; Raphael Clynes; Samuel C Silverstein
Journal:  J Exp Med       Date:  2010-01-11       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.